MedPath

Free Gingival Graft Adjunct With Low Level Laser Therapy

Not Applicable
Completed
Conditions
Wounds and Injuries
Transplants
Gingival Recession, Localized
Low-Level Light Therapy
Registration Number
NCT03425695
Lead Sponsor
Abant Izzet Baysal University
Brief Summary

The present placebo-controlled parallel design clinical study was planned to determine the effect of low level laser therapy on clinical periodontal conditions and dimensions of free gingival graft as well as postoperative pain levels in the surgical area.

Detailed Description

Background: Shrinkage of the free gingival graft (FGG) and patient's discomfort during healing period are important concerns. Therefore, this study aimed to evaluate the effect of low level laser therapy (LLLT) in terms of enhancing wound healing, reducing graft shrinkage and postoperative pain.

Methods: Thirty patients were randomly assigned to receive either FGG+ LLLT (test, n = 15) or FGG + placebo LLLT (control, n = 15). In the test group, a diode laser (aluminum-gallium-arsenide, 810 nm, 0.1 W, continuous mode, time of irradiation:60 s, energy density: 6 J/cm2, spot size:0.5 cm) was applied immediately after the FGG surgery and 1,3,7, and 14 days later. The control group received the same sequence of irradiation with the laser-off. Comparison of the graft surface areas between groups at 1st, 3rd and 6th months were made with an image-analyzing software. Complete wound epithelization, visual analogue scale (VAS) pain score of recipient site and the number of analgesic used were evaluated after the surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients >18 years old
  • Patients presenting Class I or II Miller gingival recession on vital incisors in the mandibular anterior region with no caries or restoration
  • The included teeth had also keratinized gingiva <2 mm; PI and GI<1.
  • The patients had to be systemically healthy and non-smokers.
Exclusion Criteria
  • Patients presenting active periodontal disease and probing depth >3 mm; taking medications that would interfere with the wound-healing process or that contraindicate the surgical procedure;
  • Pregnant or lactating women;
  • Patients who underwent periodontal surgery in the study area;
  • Patients with orthodontic therapy in progress were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Graft shrinkage1-, 3-, and 6-months after FGG surgery

The shrinkage of the graft area was calculated according to the differences between the graft area at baseline, 1st, 3rd, and 6th months.

Secondary Outcome Measures
NameTimeMethod
Epithelization7, 14, 21, and 28 days after FGG surgery

Epithelization was determined via bubbling test by using 3% hydrogen peroxide (H2O2). This test was carried out at 7, 14, 21, and 28 days after surgery.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.